首页 | 本学科首页   官方微博 | 高级检索  
检索        

头孢哌酮钠/舒巴坦钠治疗医院获得性肺炎46例临床观察
引用本文:沈兆梅,李华英.头孢哌酮钠/舒巴坦钠治疗医院获得性肺炎46例临床观察[J].黑龙江医学,2007,31(3):205-206.
作者姓名:沈兆梅  李华英
作者单位:鸡西市人民医院检验科,黑龙江,鸡西,158100
摘    要:目的 评价头孢哌酮钠/舒巴坦钠治疗医院荻得性肺炎的临床疗效和安全性。方法 对46例医院荻得性肺炎患者采用头孢哌酮钠/舒巴坦钠治疗,静脉给药剂量,成人2.0~4.0g/d,严重或难治性感染可增至8.0g/d,分等量,2次/d静脉滴注,疗程7~14d。结果 治疗总有效率83.3%,细菌清除率80.9%,不良反应率为4.6%。结论 头孢哌酮钠/舒巴坦钠为治疗医院获得性肺炎有效和安全的抗生素。

关 键 词:医院获得性肺炎  头胞哌酮钠/舒巴坦钠  临床疗效
文章编号:24055582
修稿时间:01 10 2007 12:00AM

Clinical Observation on Iatrogenic Acquired Pneumonia Treated with Cefoperazone Godium and Sulbactam Sodium
SHEN Zhao-mei,LI Hua-ying.Clinical Observation on Iatrogenic Acquired Pneumonia Treated with Cefoperazone Godium and Sulbactam Sodium[J].Heilongjiang Medical Journal,2007,31(3):205-206.
Authors:SHEN Zhao-mei  LI Hua-ying
Institution:SHEN Zhao - mei, LI Hua- ying ( Department of Lab, The People's Hospital of Jixi City, Jixi 158100, China )
Abstract:Objective To assess the curative effect and safety of CG and SSin treatment of iatrogenic acquired pneumonia(IAP).Methods 46 cases of such patient were treated with CG and SS 2~4g per day I.V.and severe infection the dose might increase 8 g per day for 7~14 day as a course.Results The total effective rate was 83.3% and bacteria clearance was 80.9%.The side effect rate was 4.6%.Conclusion This drug might be effective and safe for IAP.
Keywords:IAP  CG and SS  Clinical effect
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号